Cite
HARVARD Citation
Riesterer, O. et al. (2020). Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study. Radiotherapy and oncology. pp. 62-69. [Online].